Immunotherapy with chemotherapy before and after surgery for head and neck cancer
Part of Cancer, Ear, nose & throat clinical trials.
This trial tests giving a combination of immunotherapy and chemotherapy before surgery, then immunotherapy afterwards, for head and neck cancer that has reached the skull base. The goal is to see if this approach can shrink the tumor and help improve long-term outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a type of head and neck cancer (like in the gum, cheek, palate, throat, sinuses, or jaw) that has grown into the skull base.
- You have not had any prior treatment for this cancer (like chemotherapy, radiation, or immunotherapy).
- You are generally well enough to have surgery and chemotherapy.
- You can commit to regular follow-up visits and treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new immunotherapy drug (adelbelimab) combined with chemotherapy given before surgery, for people with head and neck cancer. The goal is to see if this combination can shrink the tumor and improve the chances of successful surgery.
This trial tests whether giving tislelizumab (an immunotherapy) with chemotherapy before surgery works better than surgery alone for people with head and neck cancer that has not spread to lymph nodes. It's for cancers that can be removed with surgery, and the goal is to see if the pre-surgery treatment improves outcomes.
This trial compares giving immunotherapy alone versus immunotherapy plus focused radiation before surgery for head and neck cancer. The goal is to see if adding radiation helps shrink the tumor and improve outcomes.
This trial tests a combination of an immunotherapy drug (tirelizumab) with two chemotherapy drugs before surgery for head and neck cancer that has spread to lymph nodes. The goal is to shrink the tumor and improve treatment outcomes.
This trial tests giving a combination of chemotherapy and immunotherapy before surgery for head and neck cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
This trial tests whether giving an immunotherapy drug called sintilimab before and after surgery can help treat head and neck cancer. The drug aims to boost your immune system to fight the cancer, and the goal is to improve outcomes when combined with the standard surgical treatment.
Hear when a new Head and Neck Cancer Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.